New drugs could make cancer a ‘manageable disease’ in ten years
New programme will target mutation of cells to offer ‘good quality of life’

Cancer could become a “manageable disease” within the next 10 years, according to a top scientist.
A “Darwinian” programme of new drugs from the Institute of Cancer Research (ICR) is designed to keep tumours in check and stop them being fatal.
The drugs will aim to stop cancer cells resisting treatment, allowing tumours to either be beaten completely or their growth limited to allow patients to live much longer. The team behind the drugs say they “open up the prospect of long-term control with a good quality of life”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Chemotherapy and other existing treatments sometimes fail because the deadliest cancer cells adapt and survive, causing the patient to relapse. Professor Workman of the ICR said: “Cancer's ability to adapt, evolve and become drug resistant was the cause of the vast majority of deaths from the disease and the biggest challenge we face in overcoming it.”
The Daily Mail describes the development as a “new dawn in the cancer war”. The Guardian says “the aim is to take the lethality out of cancer and turn it into a disease that… will no longer shorten or ruin lives”, while The Sun says cancer “could be ‘cured’ within a decade”.
Prof Workman said lab testing and clinical trials for the new medication would take around 10 years before it could potentially become available for patients. It will target a molecule called APOBEC, which is pivotal to the immune system, but is usurped in most cancers.
He said: “We firmly believe that, with further research, we can find ways to make cancer a manageable disease in the long term and one that is more often curable, so patients can live longer and with a better quality of life.”
He added that there must also be a “culture change” so patients no longer worry if cancer cells remain. “We would like to take some of the fear away from advanced cancer, and hope patients will benefit from new approaches that may not always give them the ‘all clear’, but could keep cancer at bay for many years.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
6 charming homes in Rhode Island
Feature Featuring an award-winning home on Block Island and a casket-making-company-turned-condo in Providence
-
Team Trump brings the MAGA playbook to Albania's elections
TODAY'S BIG QUESTION The architects of the president's 2024 victory are looking east to extend their populist reach
-
Narco subs are helping fuel a global cocaine surge
The Explainer Drug smugglers are increasingly relying on underwater travel to hide from law enforcement
-
The Y chromosome degrades over time. And men's health is paying for it
Under the radar The chromosome loss is linked to cancer and Alzheimer's
-
A bacterial toxin could be contributing to the colorectal cancer rise in young people
Under the radar Most exposure occurs in childhood
-
Why are more young people getting bowel cancer?
The Explainer Alarming rise in bowel-cancer diagnoses in under-50s is puzzling scientists
-
Five medical breakthroughs of 2024
The Explainer The year's new discoveries for health conditions that affect millions
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
-
'Beyond belief': fears of asbestos return
Under the radar Attention is returning to the dangers of the carcinogenic substance